Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL INDS | IIIN | 5.28% |
| ERICKSON AIR | EAC | 5.10% |
| ASSURED GUAR | AGO | 4.98% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Syngenta AG (SYT - Analyst Report), an agriculture chemicals producer, reported its financial results for the fourth quarter and year 2012 on Feb 6, 2013. In 2012, earnings per share, excluding restructuring and impairment charges, came in at $22.30, up 15% from $19.36 reported in 2011.
In fourth quarter 2012, sales increased 12% to $3.2 billion as North America and Latin America witnessed healthy performance with sales growing 28% and 17% year over year, respectively. The results were partially offset by a 7% decline in Europe, Africa and the Middle East and 3% in Asia Pacific.
In 2012, sales grew 7% (10% on constant currency rates) to $14.2 billion on the back of higher sales volume and healthy price increases.
Gross profits in 2012 grew 7.6% while margins stood at 49.2% compared with 49.0% in 2011. Operating expenses, including G&A, R&D and marketing and distribution, grew 5.6% in 2012 and represented 31.2% of total revenue. Operating margin was 16.1% compared with 15.5% in 2011.
Exiting 2012, the company’s cash and cash equivalents stood at $1.6 billion, down 4.0% year over year. Financial debt and other non-current liabilities were $2.5 billion compared with $2.4 billion in 2011.
Cash generated from operating activities in 2012 grew 27.4% and came in at $1.4 billion. Capital spending in the year was $508 million, up 6.1% year over year.
The same day, management announced its expansion plans for investing roughly $77 million in its corn seed protection facility in Brazil. The capacity is expected to increase four times to 1.6 million bags by 2015. This investment was particularly planned to tap the expected increase in corn production in Brazil which is expected to double by 2020.
Sygenta AG currently holds a Zacks Rank #1 (Strong Buy). Other stocks to watch out for in the industry are Gruma S.A.B. de CV (GMK - Snapshot Report) and BASF SE (BASFY), each with a Zacks Rank #1 (Strong Buy) and Monsanto Company (MON - Analyst Report), with a Zacks Rank #2 (Buy)
Get the full Analyst Report on SYT - FREE
Get the full Analyst Report on MON - FREE
Get the full on BASFY - FREE
Get the full Snapshot Report on GMK - FREE